Cigna Group $CI Shares Bought by RWA Wealth Partners LLC

RWA Wealth Partners LLC boosted its position in shares of Cigna Group (NYSE:CI) by 816.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 22,666 shares of the health services provider’s stock after buying an additional 20,192 shares during the period. RWA Wealth Partners LLC’s holdings in Cigna Group were worth $6,534,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Pathway Financial Advisers LLC boosted its stake in shares of Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after acquiring an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. lifted its holdings in Cigna Group by 17.7% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after purchasing an additional 34 shares in the last quarter. HM Payson & Co. boosted its stake in Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares during the last quarter. Carr Financial Group Corp grew its holdings in shares of Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after buying an additional 36 shares in the last quarter. Finally, Natural Investments LLC raised its position in shares of Cigna Group by 2.0% in the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after buying an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $284.31 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The stock’s fifty day moving average is $279.33 and its two-hundred day moving average is $284.41. The company has a market capitalization of $75.95 billion, a P/E ratio of 12.82, a P/E/G ratio of 0.97 and a beta of 0.27. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

CI has been the subject of several research reports. Truist Financial upped their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. TD Cowen upped their price target on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Royal Bank Of Canada cut their price target on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Finally, Sanford C. Bernstein reissued a “market perform” rating and set a $307.00 price objective on shares of Cigna Group in a research note on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $330.63.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.